Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Harcourt Investment Consulting appoints new head of alternative investments

Wednesday, May 16, 2012
Opalesque Industry Update - Harcourt, a subsidiary of Vontobel Asset Management, has appointed Jan Viebig and Georg Wessling to further expand and strengthen its expertise in alternative investments. Jan Viebig takes up the position of Head of Alternative Investments. Georg Wessling will act as Deputy Head of Alternative Investments.

Jan Viebig replaces the former CEO of Harcourt, Stephan Fritz, who has decided to leave Vontobel Asset Management. Jan Viebig has over 12 years of investment experience in alternative investments and emerging markets. He joins Harcourt from Credit Suisse, where he currently is Head of Emerging Market Equities. Before this, he was Senior Hedge Fund Manager at DWS. Jan Viebig has received several awards, amongst others the "Best Performing Equity Market Neutral Hedge Fund" from HFR in 2006, Germany's Hedge Fund Award (Silver) in 2007 and the Sauren Gold Awards from 2005 through to 2007. Jan Viebig will assume his new responsibilities in September 2012.

Georg Wessling is currently Head of Hedge Fund Advisory at Harcourt. He has 17 years of investment experience, working at Ecofin prior to joining Harcourt. He has been with Harcourt since 2005 assuming Senior Investment Roles and heading the Advisory business. In his additional role, Georg will work closely together with Jan Viebig to drive Harcourt's strategy in terms of investment and product strategies.

Axel Schwarzer, Head of Vontobel Asset Management commented: "These appointments, reflect the commitment to our clients and the ambition to further strengthen and expand our capabilities as Alternative Investments Manager."

(press release)

About Vontobel Group
The Vontobel Group is a globally-oriented Swiss private bank. The bank was first established in Zurich in 1924. Vontobel specializes in wealth management for private clients and asset management for institutional investors, as well as in investment banking. As of 31 December 2011, the Group held CHF 132 bn of assets. Around 1,500 employees worldwide provide first‑rate, customized services for clients with an international focus. The registered shares of Vontobel Holding AG are listed on the SIX Swiss Exchange. The Vontobel families and the Vontobel Foundation hold the majority of shares and votes in the company. Corporate website: www.vontobel.com

fg

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its